elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15
Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
P2860
Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4808f1b7bd41b96a7a8d8391ea064c6f3b46514
P2860
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.